05.03.24 | Vollzeit | Friedberg | Formycon AGComprised of around 240 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our
Später ansehen05.03.24 | Vollzeit | Friedberg | Formycon AGComprised of around 240 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our
Später ansehen05.03.24 | Vollzeit | Friedberg | Formycon AGComprised of around 240 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our
Später ansehen05.03.24 | Vollzeit | Friedberg | Formycon AGComprised of around 240 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our
Später ansehen05.03.24 | Vollzeit | Friedberg | Formycon AGComprised of around 240 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our
Später ansehen05.03.24 | Vollzeit | Friedberg | Formycon AGComprised of around 240 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our
Später ansehen05.03.24 | Vollzeit | Friedberg | Formycon AGComprised of around 240 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our
Später ansehen05.03.24 | Vollzeit | Friedberg | Formycon AGComprised of around 240 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our
Später ansehen05.03.24 | Vollzeit | Friedberg | Formycon AGComprised of around 240 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. Our
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Company Insurance in Friedberg kostenlos abonnieren.